Hogs get slaughtered

Anonymous

Guest
I've always been discusted by this companies greed ... even in HIV. You have Atripla and you come up with the Stribild just to make the extra 10K. Now they have the opportunity to make a real dent in one of the world's most disabling diseases and they sit at the food trof stuffing their faces.

So glad to see that the world see's you for what you are and I hope the stock takes a nose dive to reward you for your efforts ...

Oh yeah ... efforts. Lets see you continuously buy out companies and reformulate old drugs (Atripla) to make them more convenient for the public but you never develop anything original ... and you call that innovation. How about developing your own molecule and bringing it to market ... "you used care salesman"

I'm getting into the Hep C market on the opposing side and my main motivation will be to kick this companies ass.
 






Not going to happen. See what you don't know is the other side has a drug called Norvir. Take a look at what your company did in 2004 and maybe you can understand corporate greed!!!!
 






I've always been discusted by this companies greed ... even in HIV. You have Atripla and you come up with the Stribild just to make the extra 10K. Now they have the opportunity to make a real dent in one of the world's most disabling diseases and they sit at the food trof stuffing their faces.

So glad to see that the world see's you for what you are and I hope the stock takes a nose dive to reward you for your efforts ...

Oh yeah ... efforts. Lets see you continuously buy out companies and reformulate old drugs (Atripla) to make them more convenient for the public but you never develop anything original ... and you call that innovation. How about developing your own molecule and bringing it to market ... "you used care salesman"

I'm getting into the Hep C market on the opposing side and my main motivation will be to kick this companies ass.

It's company's, not companies. Companies is plural (more than 1). Get it right.
 












I've always been discusted by this companies greed ... even in HIV. You have Atripla and you come up with the Stribild just to make the extra 10K. Now they have the opportunity to make a real dent in one of the world's most disabling diseases and they sit at the food trof stuffing their faces.

So glad to see that the world see's you for what you are and I hope the stock takes a nose dive to reward you for your efforts ...

Oh yeah ... efforts. Lets see you continuously buy out companies and reformulate old drugs (Atripla) to make them more convenient for the public but you never develop anything original ... and you call that innovation. How about developing your own molecule and bringing it to market ... "you used care salesman"

I'm getting into the Hep C market on the opposing side and my main motivation will be to kick this companies ass.

And this genius this disgusted is spelled "discusted".
 


















Lol ... love the press you guys are getting ... this may be the fastest peak to pit in the history of the industry ... my bet is that you'll never see that 1 pill wonder. If the health care community is pissed about the 84K you guys are charging ... what do you think they'll do when you bring a 100K plus solution to the table ... it's not about convenience anymore ... it's cost.

I'm so loving this! Hope Abbvie's drug becomes first line and reserves you only for the "sickest of patients" ... Isn't California your home state ... what's up with that?
 






Lol ... love the press you guys are getting ... this may be the fastest peak to pit in the history of the industry ... my bet is that you'll never see that 1 pill wonder. If the health care community is pissed about the 84K you guys are charging ... what do you think they'll do when you bring a 100K plus solution to the table ... it's not about convenience anymore ... it's cost.

I'm so loving this! Hope Abbvie's drug becomes first line and reserves you only for the "sickest of patients" ... Isn't California your home state ... what's up with that?

It's not about press hard on, it's about scoreboard. And we have it. As much "press" as there's been, Sovaldi is still on formulary everywhere. Sorry make your noodle limp.
 






If your drug is so hot ... how come prescription data is flat. I'll tell you why ... you're out of the warehouse patients doctors had lined up for your $1000 pill. It's early in the game and Abbvie will have the last laugh when they price you out of the category.